gadobutrol
Generic: gadobutrol
Labeler: fresenius kabi usa, llcDrug Facts
Product Profile
Brand Name
gadobutrol
Generic Name
gadobutrol
Labeler
fresenius kabi usa, llc
Dosage Form
INJECTION
Routes
Active Ingredients
gadobutrol 604.72 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
65219-289
Product ID
65219-289_d546f4fe-ebb3-47cf-9222-563d15caa8b1
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA216081
Listing Expiration
2026-12-31
Marketing Start
2023-10-01
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
65219289
Hyphenated Format
65219-289
Supplemental Identifiers
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
gadobutrol (source: ndc)
Generic Name
gadobutrol (source: ndc)
Application Number
ANDA216081 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 604.72 mg/mL
Packaging
- 10 BOTTLE in 1 CARTON (65219-289-65) / 65 mL in 1 BOTTLE (65219-289-10)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "d546f4fe-ebb3-47cf-9222-563d15caa8b1", "openfda": {"nui": ["N0000183362", "N0000175862"], "unii": ["1BJ477IO2L"], "spl_set_id": ["c0dd1618-0bb3-4974-846b-e5afc2311ae6"], "pharm_class_epc": ["Gadolinium-based Contrast Agent [EPC]"], "pharm_class_moa": ["Magnetic Resonance Contrast Activity [MoA]"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 BOTTLE in 1 CARTON (65219-289-65) / 65 mL in 1 BOTTLE (65219-289-10)", "package_ndc": "65219-289-65", "marketing_start_date": "20231001"}], "brand_name": "Gadobutrol", "product_id": "65219-289_d546f4fe-ebb3-47cf-9222-563d15caa8b1", "dosage_form": "INJECTION", "pharm_class": ["Gadolinium-based Contrast Agent [EPC]", "Magnetic Resonance Contrast Activity [MoA]"], "product_ndc": "65219-289", "generic_name": "Gadobutrol", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Gadobutrol", "active_ingredients": [{"name": "GADOBUTROL", "strength": "604.72 mg/mL"}], "application_number": "ANDA216081", "marketing_category": "ANDA", "marketing_start_date": "20231001", "listing_expiration_date": "20261231"}